Choreoathetosis and diphenylhydantoin intoxication.

Three patients who had excessive diphenylhydantoin blood levels (29μg, 30μg, and 43μg per milliliter) developed choreoathetosis. The involuntary movements rapidly disappeared with a reduction of the diphenylhydantoin dose. One of the three patients did not have any of the common neurologic signs of diphenylhydantoin toxicity. The mechanism for the production of this phenomenon with excessive diphenylhydantoin is unknown, but it appears that the reaction is most likely to occur in epileptic patients with decreased intellect or persistent neurologic signs. ( JAMA 230:1170-1171, 1974)

[1]  S. M. Sumi,et al.  Movement disorder as a manifestation of diphenylhydantoin intoxication , 1974, Neurology.

[2]  J. Brody,et al.  Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis. , 1973, Archives of neurology.

[3]  K. Fuxe,et al.  Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating Agent , 1973, Science.

[4]  N. Gerber,et al.  Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers. , 1972, Annals of internal medicine.

[5]  G. Paulson,et al.  Use of L-dopa in the detection of presymptomatic Huntington's chorea. , 1972, The New England journal of medicine.

[6]  N. Uretsky,et al.  Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine. , 1971, Nature: New biology.

[7]  S. Brandon,et al.  A Study of Facial Dyskinesia in a Mental Hospital Population , 1971, British Journal of Psychiatry.

[8]  H. Edwards,et al.  The Significance of Brain Damage in Persistent Oral Dyskinesia , 1970, British Journal of Psychiatry.

[9]  W. Logan,et al.  Pseudodegenerative disease due to diphenylhydantoin intoxication. , 1969, Archives of neurology.

[10]  Diehl Lw.  Nil nocere. Unusual hyperkinetic syndromes following diphenylhydantoin administration. , 1969 .

[11]  J. M. Price,et al.  Abnormal copper and tryptophan metabolism and chelation therapy in anticonvulsant drug intolerance. , 1966, Diseases of the nervous system.

[12]  J. V. Morris,et al.  Rare Complication of Phenytoin Sodium Treatment , 1956, British medical journal.